Literature DB >> 2199727

Glomerular lesions in nonobese diabetic mouse: before and after the onset of hyperglycemia.

T Doi1, M Hattori, L Y Agodoa, T Sato, H Yoshida, L J Striker, G E Striker.   

Abstract

The natural history of renal lesions in nonobese diabetic mice was assessed. This strain develops a spontaneous overt insulin-dependent diabetes that has a female predominance and an autoimmune pathogenesis. We compared mice that had a normal glucose tolerance test with mice that had a diabetes of 2 to 15 weeks' duration. The glomerular surface area was increased in all diabetic mice regardless of the duration of hyperglycemia. There was an increase in the albumin/creatinine ratio in the urine of diabetic mice. Finally, nonobese diabetic mice all showed mesangial sclerosis that was more pronounced in the diabetic mice. This suggests that this strain is susceptible to glomerulosclerosis and that the occurrence of hyperglycemia results in an increase of glomerular size, mesangial sclerosis, and proteinuria, soon after glycosuria is first demonstrated.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2199727

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  17 in total

Review 1.  Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy.

Authors:  G Pugliese; F Pricci; G Romeo; G Leto; L Amadio; C Iacobini; U Di Mario
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

2.  Glomerular aging in females is a multi-stage reversible process mediated by phenotypic changes in progenitors.

Authors:  Zheng Feng; Anna Rita Plati; Qing-li Cheng; Mariana Berho; Anita Banerjee; Mylene Potier; Wen-che Jy; Andrew Koff; Liliane J Striker; Gary E Striker
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

3.  Establishment of a diabetic mouse model with progressive diabetic nephropathy.

Authors:  Akari Inada; Kojiro Nagai; Hidenori Arai; Jun-ichi Miyazaki; Keiko Nomura; Hiroshi Kanamori; Shinya Toyokuni; Yuichiro Yamada; Susan Bonner-Weir; Gordon C Weir; Atsushi Fukatsu; Yutaka Seino
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

4.  Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice.

Authors:  Y Yamamoto; I Kato; T Doi; H Yonekura; S Ohashi; M Takeuchi; T Watanabe; S Yamagishi; S Sakurai; S Takasawa; H Okamoto; H Yamamoto
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

5.  Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy.

Authors:  N A Wahab; N Yevdokimova; B S Weston; T Roberts; X J Li; H Brinkman; R M Mason
Journal:  Biochem J       Date:  2001-10-01       Impact factor: 3.857

6.  The glomerulosclerosis of aging in females: contribution of the proinflammatory mesangial cell phenotype to macrophage infiltration.

Authors:  Feng Zheng; Qing-Li Cheng; Anna-Rita Plati; Shui Qin Ye; Mariana Berho; Anita Banerjee; Mylene Potier; Edgar A Jaimes; Hong Yu; You-Fei Guan; Chung-Ming Hao; Liliane J Striker; Gary E Striker
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

7.  P-selectin deficiency exacerbates experimental glomerulonephritis: a protective role for endothelial P-selectin in inflammation.

Authors:  A R Rosenkranz; D L Mendrick; R S Cotran; T N Mayadas
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

Review 8.  Use of genetic mouse models in the study of diabetic nephropathy.

Authors:  Terri J Allen; Mark E Cooper; Hui Y Lan
Journal:  Curr Diab Rep       Date:  2004-12       Impact factor: 4.810

Review 9.  Use of genetic mouse models in the study of diabetic nephropathy.

Authors:  Terri J Allen; Mark E Cooper; Hui Y Lan
Journal:  Curr Atheroscler Rep       Date:  2004-05       Impact factor: 5.113

10.  MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy.

Authors:  Qiang Wang; Youli Wang; Andrew W Minto; Jinhua Wang; Qun Shi; Xinmin Li; Richard J Quigg
Journal:  FASEB J       Date:  2008-08-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.